PACIRA PHARMACEUTICALS INC's ticker is PCRX and the CUSIP is 695127100. A total of 267 filers reported holding PACIRA PHARMACEUTICALS INC in Q1 2024. The put-call ratio across all filers is 3.75 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2023 | $390 | +2.6% | 11,553 | -4.4% | 0.01% | -11.1% |
| Q3 2023 | $380 | -8.4% | 12,087 | +4.1% | 0.01% | 0.0% |
| Q2 2023 | $415 | -12.8% | 11,611 | -0.4% | 0.01% | -18.2% |
| Q1 2023 | $476 | +20.2% | 11,660 | +13.7% | 0.01% | +10.0% |
| Q4 2022 | $396 | -99.9% | 10,256 | +6.1% | 0.01% | -28.6% |
| Q3 2022 | $514,000 | -10.6% | 9,662 | -1.9% | 0.01% | -6.7% |
| Q2 2022 | $575,000 | -23.9% | 9,853 | -0.5% | 0.02% | -11.8% |
| Q1 2022 | $756,000 | +171.9% | 9,903 | +114.4% | 0.02% | +183.3% |
| Q4 2021 | $278,000 | -51.4% | 4,620 | -54.8% | 0.01% | -53.8% |
| Q3 2021 | $572,000 | -8.5% | 10,210 | -0.9% | 0.01% | -13.3% |
| Q2 2021 | $625,000 | -14.9% | 10,300 | -1.6% | 0.02% | -16.7% |
| Q1 2021 | $734,000 | +19.3% | 10,470 | +1.8% | 0.02% | +12.5% |
| Q4 2020 | $615,000 | +133.8% | 10,280 | +135.2% | 0.02% | +128.6% |
| Q3 2020 | $263,000 | +19.5% | 4,370 | +4.0% | 0.01% | +16.7% |
| Q2 2020 | $220,000 | – | 4,200 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tamarack Advisers, LP | 273,000 | $8,818,000 | 6.24% |
| Standard Investments LLC | 775,388 | $25,045,000 | 4.58% |
| ARMISTICE CAPITAL, LLC | 400,000 | $12,920,000 | 3.06% |
| HealthCor Management, L.P. | 1,575,000 | $50,873,000 | 2.88% |
| DARUMA CAPITAL MANAGEMENT LLC | 1,219,642 | $39,394,000 | 2.24% |
| Consonance Capital Management LP | 631,805 | $20,407,000 | 2.24% |
| Rock Springs Capital Management LP | 713,000 | $23,030,000 | 1.54% |
| Biondo Investment Advisors, LLC | 142,473 | $4,602,000 | 1.52% |
| Opus Point Partners Management, LLC | 50,000 | $1,615,000 | 1.29% |
| Partner Investment Management, L.P. | 26,690 | $862,000 | 1.14% |